Oncology Nurse Advisor
LightNews LightNews
banner
oncologynurseadv.bsky.social
Oncology Nurse Advisor
@oncologynurseadv.bsky.social
92 followers 140 following 170 posts
OncologyNurseAdvisor.com offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Posts Replies Media Videos
oncologynurseadv.bsky.social
Routine conservative #nursing practices significantly reduced the frequency and severity of phlebitis among patients with #cancer receiving chemotherapy.

https://bit.ly/44UxqaP

#OncNurse
Conservative Nursing Practices Prevent Chemotherapy-Related Phlebitis - Oncology Nurse Advisor
Researchers explored the effects of normal saline flush, ice packs, and magnesium sulfate compresses on incidence and severity of chemotherapy-related phlebitis.
bit.ly
December 17, 2025 at 11:25 PM
oncologynurseadv.bsky.social
Men receiving ADT plus androgen receptor pathway inhibitors demonstrated worsening lipid profiles and measurable elevations in CV risk, reinforcing the need for #prostatecancer–specific risk assessment tools. Published in @ascopost.bsky.social.

https://bit.ly/4oVh6h2

#pcsm
Hormone Therapy Worsens Lipids and Elevates CV Risk in Prostate Cancer - Oncology Nurse Advisor
Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.
bit.ly
December 16, 2025 at 6:37 PM
oncologynurseadv.bsky.social
Cruciferous vegetables that contain glucosinolate-derived compounds could help prevent #breastcancer. Presented at @sabcs.bsky.social #SABCS25, covered by @cancertherapyadv.bsky.social.

https://bit.ly/4q1etLn

#bcsm
Cruciferous Vegetables Appear to Reduce Breast Cancer Risk - Oncology Nurse Advisor
Investigators sought to identify a relationship between cruciferous vegetable intake and breast cancer risk in the Nurses' Health Study (NHS) and NHSII.
bit.ly
December 15, 2025 at 10:03 PM
oncologynurseadv.bsky.social
Cruciferous vegetables that contain glucosinolate-derived compounds could help prevent #breastcancer. Presented at @sabcs.bsky.social #SABCS25, covered by @cancertherapyadv.bsky.social.

https://bit.ly/4q1etLn

#bcsm
Cruciferous Vegetables Appear to Reduce Breast Cancer Risk - Oncology Nurse Advisor
Investigators sought to identify a relationship between cruciferous vegetable intake and breast cancer risk in the Nurses' Health Study (NHS) and NHSII.
bit.ly
December 15, 2025 at 9:14 PM
oncologynurseadv.bsky.social
Age-based #lungcancer screening could markedly improve detection, reduce mortality, and enhance cost-effectiveness compared with 2021 USPSTF criteria. Published in @jamanetworkopen.com.

https://bit.ly/4pwL0sV

#lcsm
Age-Based Lung Screening Improves Detection and Reduces Mortality - Oncology Nurse Advisor
Investigators evaluated the proportion, clinical characteristics, and survival of patients with lung cancer who met or were excluded from USPSTF criteria and used institutional and published data to model expanded criteria and evaluate age-based screeni...
bit.ly
December 14, 2025 at 9:54 PM
oncologynurseadv.bsky.social
Epcoritamab reduced the risk for death by 79%. Presented at #ASH25, by Dr Falchi of @mskcancercenter.bsky.social covered by @cancertherapyadv.bsky.social.

https://bit.ly/4q4fQcb

#lymsm #follicularLymphoma
December 13, 2025 at 9:11 PM
oncologynurseadv.bsky.social
In previously treated patients with melanoma, pembrolizumab therapy is associated with durable long-term survival. Published in @cancertherapyadv.bsky.social.

https://bit.ly/3MQ7vdR
Pembrolizumab Associated With Durable Long-Term Survival in Previously Treated Melanoma - Oncology Nurse Advisor
In this study, researchers investigated long-term outcomes from a real-world cohort of patients with stage IV melanoma treated with pembrolizumab following progression on prior therapies.
bit.ly
December 12, 2025 at 9:26 PM
oncologynurseadv.bsky.social
Lymphir™ (denileukin diftitox-cxdl) is now available for the treatment of R/R Stage I-III #CTCL after at least 1 prior systemic therapy. From @medicalprofref.bsky.social.

https://bit.ly/48EhSc1

#lymsm
Lymphir Now Available for R/R Cutaneous T-Cell Lymphoma - Oncology Nurse Advisor
Lymphir is supplied as a 300mcg lyophilized cake in a single-dose vial for reconstitution and further dilution.
bit.ly
December 11, 2025 at 3:49 PM
oncologynurseadv.bsky.social
Men with #CrohnDisease or ulcerative colitis have worse in-hospital outcomes after radical prostatectomy for #prostatecancer compared with men free from these IBD, a recent study From @renalurologynews.bsky.social finds.

https://bit.ly/3XKtfdC

#pcsm
Inflammatory Bowel Diseases Up Risk for Prostate Cancer Surgery Complications - Oncology Nurse Advisor
Investigators analyzed IBD subtypes and their associated risks of radical prostatectomy complications among a cohort of patients with prostate cancer to fill a knowledge gap.
bit.ly
December 10, 2025 at 9:20 PM
oncologynurseadv.bsky.social
For patients with #AML, treatment regimens using mitoxantrone hydrochloride liposome therapy were considered effective and well-tolerated in a recent multicenter study.

https://bit.ly/3YeHJCC

#leusm
Mitoxantrone Hydrochloride Liposome Regimens Effective, Safe in Acute Myeloid Leukemia - Oncology Nurse Advisor
A noninterventional, ambispective cohort analysis evaluated the real-world efficacy and safety of Lipo-MIT-containing regimens in the treatment of acute myeloid leukemia.
bit.ly
December 9, 2025 at 9:00 PM
oncologynurseadv.bsky.social
#Medicalprofessionals who use social media to educate the public on health-related topics have grown in prominence. From @renalurologynews.bsky.social.

https://bit.ly/48ULx1V

#MedicalInfluencers #HCPs
The Rise of Medical Influencers - Oncology Nurse Advisor
Medical professionals who use social media to educate the public on health-related topics have grown in prominence.
bit.ly
December 7, 2025 at 6:25 PM
oncologynurseadv.bsky.social
These treatment delays can lead to more advanced stage #cancers and “suboptimal treatment,” the researchers wrote in their report. Published in @thelancet.com and @cancertherapyadv.bsky.social.

https://bit.ly/3Mdl5YN

#bcsm #gyncsm
Women in Low-Income Countries Face Treatment Delays in Early-Stage Cancer - Oncology Nurse Advisor
Researchers assessed variations in patterns of care and time to initial treatment for women diagnosed with breast, cervical, or ovarian cancer in various countries.
bit.ly
December 6, 2025 at 9:14 PM
oncologynurseadv.bsky.social
The use of an asynchronous e-consent process for prospectively evaluating circulating tumor DNA in patients with colorectal or #pancreaticCancer appeared acceptable among patients in a recent study.

https://bit.ly/4oCHvjC

#pancsm #gicsm
Asynchronous Electronic Consent for Research Acceptable Among Patients With Cancer - Oncology Nurse Advisor
Researchers reported on patient acceptance of an e-consent tool for asynchronous delivery of study information and for receiving consent from patients.
bit.ly
December 5, 2025 at 8:54 PM
oncologynurseadv.bsky.social
Researchers developed a consensus statement to address core competencies to guide educating medical students on the use of #medicalCannabis. Published in @jamanetworkopen.com and @oncologynurseadv.bsky.social.

Read more here: ➡️ https://bit.ly/3MihDvV
Core Competencies to Guide Education on the Use of Medical Cannabis Identified
Researchers present consensus statement for core competencies to guide education for medical students on medical cannabis use. Researchers present consensus statement for core competencies to guide education for medical students on medical cannabis use.
bit.ly
December 4, 2025 at 4:48 PM
oncologynurseadv.bsky.social
Measuring certain biomarkers, including ALC, within the first 2 weeks of administering cilta-cel, a CAR T-cell therapy, may help identify patients with R/R #multipleMyeloma who are at higher risk of developing neurologic AEs.

https://bit.ly/3M9wFnJ

#JADPRO25
Absolute Lymphocyte Count May Help Monitor Neurologic Events Following Cilta-Cel Therapy in RRMM - Oncology Nurse Advisor
A retrospective study investigated the association of biomarkers pre- and post-cilta cel infusion with neurocognitive TEAEs and cranial nerve palsy in pts with RRMM.
bit.ly
December 4, 2025 at 3:49 PM
oncologynurseadv.bsky.social
A holistic approach ensures that the work environment of #oncologynurses is optimized to provide quality care, including leadership programs, adequate staffing, fair allocation of resources, and a culture of open communication.

https://bit.ly/446C9FS

#OncNurse
Optimizing Oncology Nursing Work Environment Improves Patient Care, Workflow - Oncology Nurse Advisor
A scoping review identified key factors that ensure an optimal nursing work environment that supports nurses and quality patient care.
bit.ly
December 4, 2025 at 12:53 AM
oncologynurseadv.bsky.social
Researchers characterized economic and clinical outcomes for patients treated with pemigatinib for #cholangiocarcinoma, based on whether they had ever received a diagnosis of #cancer of unknown primary.

https://bit.ly/49IdE5A
MonumenTAL-1: Talquetamab Shows Durable Responses, Tolerable Safety at 36-Month Follow Up in RRMM - Oncology Nurse Advisor
Researchers presented efficacy and ongoing safety data from MonumenTAL-1, a phase 1/2 study assessing talquetamab in patients with multiple myeloma.
bit.ly
December 3, 2025 at 3:01 AM
oncologynurseadv.bsky.social
Patients with R/R #multipleMyeloma treated with talquetamab, an anti-GPRC5D bispecific antibody, continue to show deep, durable responses with tolerable safety at extended follow up of 30-38 months. Presented at #JADPRO25, from @cancertherapyadv.bsky.social.

https://bit.ly/49IdE5A
MonumenTAL-1: Talquetamab Shows Durable Responses, Tolerable Safety at 36-Month Follow Up in RRMM - Oncology Nurse Advisor
Researchers presented efficacy and ongoing safety data from MonumenTAL-1, a phase 1/2 study assessing talquetamab in patients with multiple myeloma.
bit.ly
December 1, 2025 at 5:53 PM
oncologynurseadv.bsky.social
#Lungcancer screening uptake increased with a direct-to-patient digital health intervention. Published in @jama.com.

https://bit.ly/3XgBTQP

#lcsm #LungCancerAwarenessMonth #LCAM
Direct-to-Patient Intervention Increases Lung Cancer Screening Completion - Oncology Nurse Advisor
Researchers explored whether a direct-to-patient digital intervention could increase the number of lung cancer screening CTs among patients in 2 US health systems.
bit.ly
November 30, 2025 at 6:22 PM
oncologynurseadv.bsky.social
#PhysicalActivity, particularly at a consistent level in line with guideline recommendations, significantly reduces both risk of and mortality from #digestiveSystemCancers. Published in @jamaoncology.com and @cancertherapyadv.bsky.social.

https://bit.ly/4ogfKNq
Consistent Physical Activity Reduces Risk of Digestive System Cancers, Research Suggests - Oncology Nurse Advisor
Alongside reducing body mass index, “physical activity may have systematic anticancer effect, such as improving insulin sensitivity, reducing hyperinsulinemia, lowering systemic inflammation, and enhancing immune function,” researchers reported.
bit.ly
November 29, 2025 at 9:11 PM
oncologynurseadv.bsky.social
Treatment-free relapse is a feasible target for patients with #chronicMyeloidLeukemia living in low- and middle-income countries. Presented at #ESMO25, from @hematologyadvisor.bsky.social.

https://bit.ly/4ppEsMq

#CML #leusm
Patients With CML Living in LMICs May Reach High TFR Rates - Oncology Nurse Advisor
Researchers evaluated long-term outcomes among patients with CML living in LMICs who received imatinib through financial assistance from the Max Foundation.
bit.ly
November 28, 2025 at 8:57 PM
oncologynurseadv.bsky.social
A subset of patients with refractory advanced #penilecancer may respond to the immune checkpoint inhibitor avelumab, but how to identify these patients is unclear. From @renalurologynews.bsky.social.

https://bit.ly/43PJkC8

#ESMO25
Avelumab Does Not Meaningfully Prolong Survival in Advanced Penile Cancer - Oncology Nurse Advisor
Immune checkpoint inhibitors have shown efficacy in other HPV-related cancers, so a phase 2 trial tested the anti-PDL-1 antibody avelumab in patients with locally advanced or metastatic penile cancer with or without previous platinum-based chemotherapy.
bit.ly
November 27, 2025 at 3:46 PM
oncologynurseadv.bsky.social
Researchers developed a model to predict survival in patients with symptomatic #spinalMetastasis.

https://bit.ly/4rAGc7w

#spineMets
Survival Prediction Model for Patients With Symptomatic Spinal Metastasis - Oncology Nurse Advisor
Researchers reported on a prediction model developed to determine which patients with spinal metastases were likely to benefit from surgery.
bit.ly
November 26, 2025 at 3:49 PM
oncologynurseadv.bsky.social
#Exerkines, the molecular signals released through physical exertion, may be protective against radiation toxicities for patients with #prostatecancer.

https://bit.ly/4ilZXv5

#pcsm
Researchers Explore Exercise, Exerkines as Next-Generation Radioprotectors - Oncology Nurse Advisor
Exerkines, the molecular signals released through physical exertion, may be protective against radiation toxicities for patients with prostate cancer.
bit.ly
November 26, 2025 at 12:35 AM
oncologynurseadv.bsky.social
#Nipocalimab, a monoclonal antibody that inhibits the neonatal FcRN, has shown early therapeutic potential in FNAIT, a rare antibody-mediated disorder of #pregnancy. Published in @rarediseaseadvisor.bsky.social.

https://bit.ly/4i7aoTc
Emerging FcRN Blockade May Transform Management of FNAIT
Intravenous immunoglobulin remains the standard of care for preventing thrombocytopenia and intracranial hemorrhage in FNAIT.
bit.ly
November 24, 2025 at 5:54 PM